West Pharmaceutical Services Inc. (NYSE:WST) has been downgraded to Sell in a statement by Zacks Investment Research earlier today.
- Updated: September 28, 2016
Zacks Investment Research has downgraded West Pharmaceutical Services Inc. (NYSE:WST) to Sell in a report released on 9/28/2016.
Boasting a price of $74.09, West Pharmaceutical Services Inc. (NYSE:WST) traded 1.70% higher on the day. With the last close down -0.56% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. West Pharmaceutical Services Inc. has recorded a 50-day average of $80.45 and a two hundred day average of $75.18. Volume of trade was up over the average, with 581,829 shares of WST changing hands over the typical 353,966
Recent Performance Chart
West Pharmaceutical Services Inc. has a 52 week low of $52.79 and a 52 week high of $84.33 with a P/E ratio of 54.45 The company’s market cap is currently $0.
In addition to Zacks Investment Research reporting its stock price target, a total of 4 brokerages have issued a research note on the company. The average stock price target is $66.00 with 2 firms rating the stock a strong buy, 1 firm rating the stock a buy, 1 firm rating the stock a hold, zero analysts rating the company a underperform, and lastly zero analysts rating the company a sell.
More About West Pharmaceutical Services Inc. (NYSE:WST)
West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries. The Company's segments include Pharmaceutical Packaging Systems segment (Packaging Systems) and the Pharmaceutical Delivery Systems segment (Delivery Systems). Its Packaging Systems segment includes primary packaging components and systems for injectable drug delivery, other components used in syringe, intravenous and blood collection systems, and prefillable syringe components. Its Delivery Systems segment includes safety and administration systems, multi-component systems for drug containment and administration and various custom contract-manufacturing solutions.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.